Analyses of YBX1 interaction networks reveal potential therapeutic targets for adenocarcinoma, while exploring PABPC1, an YBX1 interaction partner, offers avenues for discovering new drug targets in lung adenocarcinoma (139, 140). This evidence concerns the gene YBX1 and lung adenocarcinoma.